Market revenue in 2023 | USD 165.9 million |
Market revenue in 2030 | USD 299.9 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the Singapore home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank Group, the country’s population aged 65 & above accounted for nearly 10.6% of the total population in 2017 and around 12.4% in 2019. Furthermore, according to Cable News Network, by 2030, around 20.5% of the country’s population is estimated to be aged above 65. The rise in geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. The Home Nursing Foundation (Singapore) funded nearly 4,500 patients in 2016 in comparison with 4,050 patients in 2015.
In addition, funds such as the Seniors' Mobility and Enabling Fund (SMF) focus on providing subsidies to Singaporean senior citizens to receive home-based care. Such factors are boosting the market growth in the country. However, home-care services in the country are mainly funded by the private sector and/or NGOs, which have limited subsidies, thus home-care services are still relatively expensive, thereby limiting access to and affordability of these services for majority of the people in Singapore, especially those covered under public insurance Medisave.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Singapore home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account